From the Department of Pharmacology and Toxicology, Medical College of
Wisconsin, Milwaukee.
Correspondence to Garrett J. Gross, PhD, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226.
BackgroundOur laboratory has
previously shown that
Methods and ResultsAnesthetized, open chest, male Wistar
rats were assigned to 1 of 14 groups. All animals were subjected to 30
minutes of occlusion and 2 hours of reperfusion. Ischemic
preconditioning was elicited by three 5-minute occlusion periods
interspersed with 5 minutes of reperfusion. Two doses of
7-benzylidenenaltrexone (BNTX; 1 and 3 mg/kg IV), a selective
ConclusionsThese results indicate that
© 1998 American Heart Association, Inc.
Basic Science Reports
Ischemic Preconditioning in the Intact Rat Heart Is Mediated by
1- But Not µ- or
-Opioid Receptors
-opioid receptors are involved in the
cardioprotective effect of ischemic preconditioning in the rat
heart. However, this class of receptors consists of two subtypes,
1 and
2, and µ- or
-opioid
receptors may also exist in the heart. Therefore, the purpose of the
present study was to test the hypothesis that ischemic
preconditioning is mediated through stimulation of one or both
-opioid receptor subtypes.
1-opioid receptor antagonist, or naltriben
(NTB; 1 and 3 mg/kg IV), a selective
2-opioid receptor
antagonist, were given before ischemic
preconditioning. To test for a role of µ-opioid receptors, rats were
pretreated with ß-funaltrexamine (ß-FNA; 15 mg/kg SC), an
irreversible µ-opioid receptor antagonist, 24 hours
before ischemic preconditioning or given the µ-opioid
receptor agonist
D-Ala,2N-Me-Phe,4glycerol5-enkephalin
(DAMGO) as three 5-minute infusions (1, 10, and 100 µg/kg per
infusion IV, respectively) interspersed with 5-minute drug-free periods
before the prolonged ischemic and reperfusion periods
(lowDAMGO, medDAMGO, and hiDAMGO, respectively). The involvement of
-opioid receptors was tested by administering one of two doses of
nor-binaltorphimine (nor-BNI; 1 and 5
mg/kg IV) before ischemic preconditioning. Infarct size (IS) as
a percent of the area at risk (AAR) was measured by
triphenyltetrazolium stain.
Ischemic preconditioning markedly reduced IS/AAR (14±4%,
P<.05) compared with control (55±4%). NTB, ß-FNA,
and nor-BNI were unable to block the cardioprotective
effect of ischemic preconditioning. In addition, DAMGO had no
effect on IS/AAR. However, the high dose of BNTX (3 mg/kg IV)
significantly attenuated the cardioprotective effect of
ischemic preconditioning (39±5%; P<.05 versus
control and ischemic preconditioning).
1-opioid
receptors play an important role in the cardioprotective effect of
ischemic preconditioning in the rat heart.
Key Words: receptors ischemia myocardial infarction signal transduction heart diseases
This article has been cited by other articles:
![]() |
S. Lorsomradee, S. Cromheecke, S. Lorsomradee, and S. G De Hert Cardioprotection with Volatile Anesthetics in Cardiac Surgery Asian Cardiovasc Thorac Ann, June 1, 2008; 16(3): 256 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Zatta, H. Kin, D. Yoshishige, R. Jiang, N. Wang, J. G. Reeves, J. Mykytenko, R. A. Guyton, Z.-Q. Zhao, J. L. Caffrey, et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1444 - H1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Deo, M. A. Barlow, L. Gonzalez, D. Yoshishige, and J. L. Caffrey Cholinergic location of {delta}-opioid receptors in canine atria and SA node Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H829 - H838. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Dickson, C. P. Hogrefe, P. S. Ludwig, L. W. Ackermann, L. L. Stoll, and G. M. Denning Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H402 - H408. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Yu, Y.-H. Li, G. T. C. Wong, T. M. Wong, and M. G. Irwin Remifentanil preconditioning confers delayed cardioprotection in the rat Br. J. Anaesth., November 1, 2007; 99(5): 632 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iwata, S. Inoue, M. Kawaguchi, M. Nakamura, N. Konishi, and H. Furuya Effects of delta-opioid receptor stimulation and inhibition on hippocampal survival in a rat model of forebrain ischaemia Br. J. Anaesth., October 1, 2007; 99(4): 538 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-H. Huang, H.-Q. Wang, W. R. Roeske, Y. Birnbaum, Y. Wu, N.-P. Yang, Y. Lin, Y. Ye, D. J. McAdoo, M. G. Hughes, et al. Mediating {delta}-opioid-initiated heart protection via the beta2-adrenergic receptor: role of the intrinsic cardiac adrenergic cell Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H376 - H384. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Deo, S. Johnson-Davis, M. A. Barlow, D. Yoshishige, and J. L. Caffrey Repeated {delta}1-opioid receptor stimulation reduces {delta}2-opioid receptor responses in the SA node Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2246 - H2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Patel, B. P. Head, H. N. Petersen, I. R. Niesman, D. Huang, G. J. Gross, P. A. Insel, and D. M. Roth Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and {delta}-opioid receptors Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H344 - H350. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Zhao and J. Vinten-Johansen Postconditioning: Reduction of reperfusion-induced injury Cardiovasc Res, May 1, 2006; 70(2): 200 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Barlow, S. Deo, S. Johnson, and J. L. Caffrey Vagotonic effects of enkephalin are not mediated by sympatholytic mechanisms. Experimental Biology and Medicine, April 1, 2006; 231(4): 387 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
Michael. J. Watson, J. D. S. Holt, S. J. O'Neill, K. Wei, W. Pendergast, G. J. Gross, P. J. Gengo, and K.-J. Chang ARD-353 [4-((2R,5S)-4-(R)-(4-Diethylcarbamoylphenyl)(3-hydroxyphenyl)methyl)-2,5-dimethylpiperazin-1-ylmethyl)benzoic Acid], A Novel Nonpeptide {delta} Receptor Agonist, Reduces Myocardial Infarct Size without Central Effects J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 423 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ockaili, R. Natarajan, F. Salloum, B. J. Fisher, D. Jones, A. A. Fowler III, and R. C. Kukreja HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H542 - H548. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barrere-Lemaire, N. Combes, C. Sportouch-Dukhan, S. Richard, J. Nargeot, and C. Piot Morphine mimics the antiapoptotic effect of preconditioning via an Ins(1,4,5)P3 signaling pathway in rat ventricular myocytes Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H83 - H88. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Okubo, Y. Tanabe, K. Takeda, M. Kitayama, S. Kanemitsu, R. C. Kukreja, and N. Takekoshi Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of {delta}-opioid receptor Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1786 - H1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Horiuchi, M. Kawaguchi, T. Sakamoto, N. Kurita, S. Inoue, M. Nakamura, N. Konishi, and H. Furuya The Effects of the {delta}-Opioid Agonist SNC80 on Hind-Limb Motor Function and Neuronal Injury After Spinal Cord Ischemia in Rats Anesth. Analg., July 1, 2004; 99(1): 235 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weinbrenner, F. Schulze, L. Sarvary, and R. H Strasser Remote preconditioning by infrarenal aortic occlusion is operative via {delta}1-opioid receptors and free radicals in vivo in the rat heart Cardiovasc Res, February 15, 2004; 61(3): 591 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Addison, P. C. Neligan, H. Ashrafpour, A. Khan, A. Zhong, M. Moses, C. R. Forrest, and C. Y. Pang Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1435 - H1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. K. Jackson, D. Yoshishige, and J. L. Caffrey Bimodal {delta}-opioid receptors regulate vagal bradycardia in canine sinoatrial node Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1332 - H1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cao, L. Liu, and D. M. Van Winkle Activation of {delta}- and {kappa}-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1032 - H1039. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Pyle, Y. Chen, and P. A. Hofmann Cardioprotection through a PKC-dependent decrease in myofilament ATPase Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1220 - H1228. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Peart and G. J. Gross Adenosine and opioid receptor-mediated cardioprotection in the rat: evidence for cross-talk between receptors Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H81 - H89. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Coles Jr., D. C. Sigg, and P. A. Iaizzo Role of kappa -opioid receptor activation in pharmacological preconditioning of swine Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2091 - H2099. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Qin, J. M. Downey, and M. V. Cohen Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H727 - H734. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kodani, Y.-T. Xuan, K. Shinmura, H. Takano, X.-L. Tang, and R. Bolli delta -Opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1943 - H1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kato and P. Foex Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists: [La protection myocardique contre les lesions d'ischemie-reperfusion par des anesthesiques : une mise a jour pour les anesthesiologistes] Can J Anesth, October 1, 2002; 49(8): 777 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Fryer, J. A Auchampach, and G. J Gross Therapeutic receptor targets of ischemic preconditioning Cardiovasc Res, August 15, 2002; 55(3): 520 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Y. Zhang, B. C. McPherson, H. Liu, T. Baman, S. S. McPherson, P. Rock, and Z. Yao Role of Nitric-Oxide Synthase, Free Radicals, and Protein Kinase C delta in Opioid-Induced Cardioprotection J. Pharmacol. Exp. Ther., June 1, 2002; 301(3): 1012 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Sigg, J. A. Coles Jr., P. R. Oeltgen, and P. A. Iaizzo Role of delta -opioid receptor agonists on infarct size reduction in swine Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H1953 - H1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Jackson, M. Farias, A. Stanfill, and J. L. Caffrey Delta Opioid Receptors Inhibit Vagal Bradycardia in the Sinoatrial Node Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2001; 6(4): 385 - 393. [Abstract] [PDF] |
||||
![]() |
R. M. Fryer, Y. Wang, A. K. Hsu, H. Nagase, and G. J. Gross Dependence of delta 1-Opioid Receptor-Induced Cardioprotection on a Tyrosine Kinase-Dependent but Not a Src-Dependent Pathway J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 477 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karck, S. Tanaka, S. F. Bolling, A. Simon, T.-P. Su, P. R. Oeltgen, and A. Haverich Myocardial protection by ischemic preconditioning and {delta}-opioid receptor activation in the isolated working rat heart J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 986 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Sigg, J. A. Coles Jr, W. J. Gallagher, P. R. Oeltgen, and P. A. Iaizzo Opioid preconditioning: myocardial function and energy metabolism Ann. Thorac. Surg., November 1, 2001; 72(5): 1576 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, M. V Cohen, M. Behrends, J. M Downey, and G. Heusch Signal transduction of ischemic preconditioning Cardiovasc Res, November 1, 2001; 52(2): 181 - 198. [Full Text] [PDF] |
||||
![]() |
H. H. Patel and G. J. Gross Diazoxide induced cardioprotection: what comes first, KATP channels or reactive oxygen species? Cardiovasc Res, September 1, 2001; 51(4): 633 - 636. [Full Text] [PDF] |
||||
![]() |
W. G. Pyle, J. W. Lester, and P. A. Hofmann Effects of {kappa}-opioid receptor activation on myocardium Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H669 - H678. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schulz, P. Gres, and G. Heusch Role of endogenous opioids in ischemic preconditioning but not in short-term hibernation in pigs Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2175 - H2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ockaili, P. Bhargava, and R. C. Kukreja Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial KATP channel Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2406 - H2411. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fryer, P. F. Pratt, A. K. Hsu, and G. J. Gross Differential Activation of Extracellular Signal Regulated Kinase Isoforms in Preconditioning and Opioid-Induced Cardioprotection J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 642 - 649. [Abstract] [Full Text] |
||||
![]() |
R. M. Fryer, Y. Wang, A. K. Hsu, and G. J. Gross Essential activation of PKC-{delta} in opioid-initiated cardioprotection Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1346 - H1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. LEE and C. W. EMALA Protein Kinase C and Gi/o Proteins Are Involved in Adenosine- and Ischemic Preconditioning--Mediated Renal Protection J. Am. Soc. Nephrol., February 1, 2001; 12(2): 233 - 240. [Abstract] [Full Text] |
||||
![]() |
G.-Y. Wang, S. Wu, J.-M. Pei, X.-C. Yu, and T.-M. Wong {kappa}- but not {delta}-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H384 - H391. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pepe Dysfunctional ischemic preconditioning mechanisms in aging Cardiovasc Res, January 1, 2001; 49(1): 11 - 14. [Full Text] [PDF] |
||||
![]() |
S. P. Bell, M. N. Sack, A. Patel, L. H. Opie, and D. M. Yellon Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2296 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Pyle, T. D. Smith, and P. A. Hofmann Cardioprotection with kappa -opioid receptor stimulation is associated with a slowing of cross-bridge cycling Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1941 - H1948. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Younes, S. Pepe, B. A. Barron, H. A. Spurgeon, E. G. Lakatta, and J. L. Caffrey Cardiac synthesis, processing, and coronary release of enkephalin-related peptides Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1989 - H1998. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fryer, A. K. Hsu, H. Nagase, and G. J. Gross Opioid-Induced Cardioprotection against Myocardial Infarction and Arrhythmias: Mitochondrial versus Sarcolemmal ATP-Sensitive Potassium Channels J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 451 - 457. [Abstract] [Full Text] |
||||
![]() |
M. V. Cohen, X.-M. Yang, T. Neumann, G. Heusch, and J. M. Downey Favorable Remodeling Enhances Recovery of Regional Myocardial Function in the Weeks After Infarction in Ischemically Preconditioned Hearts Circulation, August 1, 2000; 102(5): 579 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Johnston Preconditioning the Brain and Heart: Implications for Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 2000; 4(2): 70 - 79. [Abstract] [PDF] |
||||
![]() |
B. A. Barron Cardiac Opioids Experimental Biology and Medicine, May 1, 2000; 224(1): 1 - 7. [Abstract] [Full Text] |
||||
![]() |
R. M. Fryer, J. T. Eells, A. K. Hsu, M. M. Henry, and G. J. Gross Ischemic preconditioning in rats: role of mitochondrial KATP channel in preservation of mitochondrial function Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H305 - H312. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ockaili, V. R. Emani, S. Okubo, M. Brown, K. Krottapalli, and R. C. Kukreja Opening of mitochondrial KATP channel induces early and delayed cardioprotective effect: role of nitric oxide Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2425 - H2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takasaki, R. A. Wolff, G. L. Chien, and D. M. van Winkle Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta -opioid receptors Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2442 - H2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. V. Chen, S. C. Body, and S. K. Shernan Myocardial Preconditioning: Characteristics, Mechanisms, and Clinical Applications Seminars in Cardiothoracic and Vascular Anesthesia, July 1, 1999; 3(2): 85 - 97. [Abstract] [PDF] |
||||
![]() |
S. Wu, H. Y. Li, and T. M. Wong Cardioprotection of Preconditioning by Metabolic Inhibition in the Rat Ventricular Myocyte : Involvement of {kappa}-Opioid Receptor Circ. Res., June 25, 1999; 84(12): 1388 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Liang and G. J. Gross Direct Preconditioning of Cardiac Myocytes via Opioid Receptors and KATP Channels Circ. Res., June 25, 1999; 84(12): 1396 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
|